An underground market for unapproved slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Experimental Drug Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are urged to message these profiles directly for supplier links, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where communities with numerous of participants share “before and after” photos, administration instructions and assertions of next-day British shipping. Vendors market the substance there before directing customers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Experts Express Concerns
Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users administering products of unknown origin.
Some experts stated the demand for retatrutide could be linked to the increasing cost of licensed slimming products such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the British medical regulations.
Several influencers try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, advertising, and customer laws, potentially leading to fines, legal action or imprisonment.
Service Reaction and Material Elimination
Based on TikTok, the service has taken down violative content and prohibited related hashtags and query recommendations. The organization said it was dedicated to keeping the service safe and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Research also discovered communities with up to 9,000 participants selling retatrutide using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, filled with photos of weight loss, glowing testimonials and step-by-step guides for mixing or injecting at residence.
Within moments of entering one community, a seller shared WhatsApp details, where most transactions occur. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about weight, health issues or previous experience.
Product Information and Pricing
Inside these groups, posts display dark colored packages with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how much time a injector should last, sellers give conflicting responses ranging from a several days to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for the messaging service stated it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are administering substances they cannot confirm. Although the science behind this drug is sound, these online products may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to current price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake treatments are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her staff has previously encountered patients injured by self-injection from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a company investigational product not yet authorized … may expose users to possibly serious medical dangers”.
